Encodia is a leading technology company that is revolutionizing the field of protein sequencing. With their breakthrough reverse-translation technology called ProteoCode™, they are driving protein sequencing at scale to accelerate innovations in human health. By looking at things from a novel perspective, Encodia is solving the most challenging scientific problems in order to enable personalized medicine and unlock countless possibilities for discovery.

ProteoCode™ offers scalable solutions for population-level studies and integrates seamlessly with multiomic approaches. It provides in-depth information on cellular processes, ultimately paving the way for advancements in human health. Using amino acid barcoded libraries and NGS-based protein analysis, Encodia achieves scale and throughput on par with genomics technology.

Their data analysis is also compatible with multiomics, enabling a comprehensive understanding of biological systems. Encodia is comprised of an elite team of innovative thinkers who have a proven track record of developing and launching biotechnologies that have led to groundbreaking discoveries. They offer endless opportunities for those who want to work on the cutting edge of technology and unlock the full potential of biology.

Contact Encodia to learn more about their groundbreaking technology and join their mission to unlimit biology